Biocryst Pharmaceuticals reported $277.28M in Assets for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Adamas Pharmaceuticals ADMS:US 150.64M 18.6M
Alexion Pharmaceuticals ALXN:US $ 18650.2M 547.2M
Alnylam Pharmaceuticals ALNY:US $ 3509.43M 254.16M
Biocryst Pharmaceuticals BCRX:US $ 277.28M 7.15M
Chemocentryx CCXI:US $ 467.67M 31.44M
Chugai Pharma 4519:JP Y 1275767M 131140M
Daiichi Sankyo 4568:JP Y 2062470M 22708M
Enanta Pharmaceuticals ENTA:US $ 450.44M 17.33M
Gilead Sciences GILD:US $ 67984M 492M
GlaxoSmithKline GSK:LN 77011M 1068M
Glaxosmithkline GSK:US $ 77011M 1068M
Intra Cellular Therapies ITCI:US $ 625.7M 48.79M
IONIS PHARMACEUT IONS:US $ 2497.07M 248.52M
Karyopharm Therapeutics KPTI:US $ 286.57M 11.66M
Mirati Therapeutics MRTX:US $ 1355.7M 25.14M
Neurocrine Biosciences NBIX:US $ 1956.4M 110M
Novavax NVAX:US $ 2749.59M 141.22M
Ptc Therapeutics PTCT:US $ 2058.67M 53.27M
Regeneron Pharmaceuticals REGN:US $ 21485.9M 3713.7M
Sarepta Therapeutics SRPT:US $ 2759.07M 6.16M
Ultragenyx Pharmaceutical RARE:US $ 1512.44M 85.32M
Vertex Pharmaceuticals VRTX:US $ 12221.69M 106.63M
YTE INCY:US $ 3904.62M 243.19M
Zogenix ZGNX:US $ 540.07M 40.89M